Effect of antiepileptic drugs and reactive oxygen species on folate receptor 1 (FOLR1)-dependent 5-methyltetrahydrofolate transport.
Metabolic breakdown of valproate (VPA), carbamazepine (CBZ) and phenytoin (PHT) by the cytochrome P450 pathway generates toxic drug intermediates and reactive oxygen species (ROS). This mechanism has been suspected to play a role in the pathogenesis of secondary cerebral folate deficiency (CFD). Using KB-cell cultures, highly expressing the folate receptor 1 (FOLR1), the effect of antiepileptic drugs (AEDs) and reactive oxygen species (ROS) on the FOLR1 dependent 5-methyltetrahydrofolate (MTHF) uptake was studied. MTHF uptake is time and concentration dependent and shows saturation kinetics. At physiological MTHF concentrations the high-affinity FOLR1 represents the predominant mechanism for cellular incorporation, while at high MTHF concentrations other transport mechanisms participate in folate uptake. Exposure to PHT for more than 8h led to a higher MTHF uptake and decreased cell count, whereas MTHF uptake remained unaltered by VPA and CBZ. However, exposure to superoxide and hydrogen peroxide radicals significantly decreased cellular MTHF uptake. By specific elimination and downregulation of FOLR1 using phosphatidyl-inositol-specific phospholipase C (PIPLC) and siRNA silencing, it was shown that ROS not only inhibited FOLR1 mediated MTHF uptake but also affected all other mechanisms of membrane-mediated MTHF uptake. Generation of ROS with the use of AED might therefore provide an additional explanation for the disturbed folate transfer across the blood-CSF barrier in patients with CFD.
Opladen
Thomas
T
University Children's Hospital Heidelberg, Division of Inborn Metabolic Diseases, Heidelberg, Germany.
Blau
Nenad
N
Ramaekers
Vincent Th
VT
D000927:Anticonvulsants / Q000494:pharmacology*; D002220:Carbamazepine / Q000378:metabolism; D058975:Folate Receptor 1 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D010672:Phenytoin / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013763:Tetrahydrofolates / Q000378:metabolism*; D014635:Valproic Acid / Q000378:metabolism
D000927:Anticonvulsants; D058975:Folate Receptor 1; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D013763:Tetrahydrofolates; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; C005984:5-methyltetrahydrofolate